| 0 |
In situ, intraepithelial, noninvasive
Papillary
- Non-infiltrating or non-invasive papillary transitional cell carcinoma
- Non-infiltrating or non-invasive papillary urothelial carcinoma
- Papillary transitional cell carcinoma, with inferred description of non-invasion
- Papillary urothelial carcinoma, with inferred description of non-invasion
Nonpapillary
- Carcinoma in situ, NOS
- Sessile (flat) (solid) carcinoma in situ
- Transitional cell carcinoma in situ
- Urothelial carcinoma (in situ, non-infiltrating, non-invasive)
Multifocal non-invasive tumors
Urethra-Prostatic
Carcinoma in situ involving (WITHOUT stromal invasion)
- Periurethral or prostatic ducts
- Prostatic urethra |
| 1 |
Localized only (localized, NOS)
- Muscularis invaded
- Subepithelial connective tissue (lamina propria, submucosa) invaded |
| 2 |
Regional by direct extension only
- All sites
+ Bladder neck
- Urethra
+ Corpus cavernosum
+ Corpus spongiosum
+ Periurethral muscle (sphincter muscle)
+ Vagina (anterior, NOS)
- Prostatic urethra
+ Periprostatic fat (beyond prostate capsule)
+ Prostate (prostatic stroma)
+ Prostatic ducts |
| 3 |
Regional lymph node(s) involved only
- Iliac (common, external, internal [hypogastric] [obturator], NOS)
- Inguinal (superficial [femoral], NOS)
- Inguinal, deep (Node of Cloquet or Rosenmuller [highest deep inguinal], NOS)
- Pelvic, NOS (including true pelvis)
- Perivesical
- Presacral
- Sacral, NOS
- Regional lymph node(s), NOS
+ Lymph node(s), NOS |
| 4 |
Regional by BOTH direct extension AND regional lymph node(s) involved
- Codes (2) + (3) |
| 7 |
Distant site(s)/lymph node(s) involved
- Distant site(s) (including further contiguous extension)
+ All sites
* Adjacent organ(s), NOS
* Bladder wall
+ Prostatic urethra
* Rectal wall
- Distant lymph node(s), NOS
- Distant metastasis, NOS
+ Carcinomatosis
+ Distant metastasis WITH or WITHOUT distant lymph node(s) |
| 9 |
Unknown if extension or metastasis |
